NICE has today (4 February 2020) published the outcome of the appeal against its final draft guidance (FAD) on erenumab (also called Aimovig and made by Novartis) for preventing chronic migraine.
An expanded evidence base could allow NICE to address evidence gaps and enhance reviews of the impact of our guidance
Applications close on Wednesday 4 March 2020
Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
A new treatment option for patients with previously treated follicular lymphoma (grade 1 to 3A) has been approved by NICE.
NICE has today, 30 January 2020, published a simple guide to the way we develop our guidance and standards.
More evidence on the clinical and cost effectiveness of esketamine needed
Health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developing chronic conditions.
Dame Philippa Russell, Vice-President of Carers UK and Topic Adviser for the NICE guideline on Supporting Adult Carers
Community pharmacy teams have the potential to play a greater role in health promotion and prevention says NICE, in a new draft quality standard.
Larotrectinib (also called Vitrakvi and made by Bayer), a new treatment for a range of cancers, can’t be recommended for use in the NHS because at its current price, it doesn’t have the potential to be cost-effective.
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in final guidance published today (15 January 2020).
Doctors can check on their patients remotely using Reveal LINQ monitor
Submit your shared learning entry by 4 March 2020 for a chance to be one of our 20 finalists at this year’s NICE Conference
Paper looks at how histology-independent cancer drugs might be appraised
Recommendation ID NG41/3 Question Thoracic and lumbosacral assessment tool:- After injury, what is the best method of clinical assessment
Recommendation ID NG136/2 Question ion (with or without type 2 diabetes), what are the appropriate risk and blood pressure thresholds for
Recommendation ID CG144/4 Question Thrombolytic therapy for DVT:- What is the clinical and cost effectiveness of clot removal using catheter-directed
Recommendation ID TA575/1 Question What are the costs associated with best supportive care? Any explanatory notes(if applicable)
Recommendation ID NG147/5 Question What are the clinically and cost-effective surgical approaches to managing complicated acute diverticulitis
Recommendation ID CG153/5 Question Topical therapy:- In people of all ages with psoriasis: 1. How should topical therapies be used to maintain
Recommendation ID CG150/3 Question Topiramate to prevent recurrent cluster headache:- Is topiramate a clinically and cost effective prophylactic
Recommendation ID NG77/1 Question Toric lenses for astigmatism:- What is the cost effectiveness of toric lenses compared with on-axis or
Recommendation ID NG29/4 Question Training and education of healthcare professionals:- Does ensuring that all hospital healthcare professionals
Recommendation ID NG150/3 Question What training, support or interventions help to reduce caring-related accidents or incidents?
Recommendation ID NG27/1 Question Training for hospital and social care practitioners:- What is the effect of hospital discharge or transitions
Recommendation ID CG136/1 Question Training in the use of the national quality standard and guidance on service user experience of care:-
Recommendation ID CG128/1 Question Training professionals:- Does training professionals to recognise signs and symptoms of autism lead
Recommendation ID NG21/3 Question Training:- What are the effects of different approaches to home care training on outcomes for people
Recommendation ID NG43/8 Question Transition in special groups: looked-after young people:- What is the most effective way of supporting
Recommendation ID NG43/7 Question Transition in special groups: young offenders institutions:- What is the most effective way of supporting
Recommendation ID NG43/1 Question Transition support for young adults:- What approaches to providing transition support for those who move
Recommendation ID NG50/4 Question Transjugular intrahepatic portosystemic shunt:- What is the quality of life in people who have had a
Recommendation ID IPG656/1 Question The evidence on the safety of transurethral laser ablation for recurrent non-muscle-invasive bladder
Recommendation ID NG69/4 Question Treating an eating disorder in people with a comorbidity:- What is the impact of comorbidities on treatment
Recommendation ID CG177/3 Question Treating common presentations of osteoarthritis for which there is little evidence:- What are effective
Recommendation ID CG170/4 Question Treating comorbid anxiety in children and young people with autism:- What is the comparative clinical
Recommendation ID NG33/3 Question For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?
Recommendation ID NG50/2 Question Treating small oesophageal varices:- Do non-selective beta-blockers improve survival and prevent first
Recommendation ID NG20/1 Question Serological testing in people who have IgA deficiency:- What is the sensitivity and specificity of IgG
Recommendation ID NG20/2 Question Serological testing in people who test negative for anti-transglutaminase:- What is the sensitivity and
Recommendation ID NG22/2 Question Service delivery models:- Which models of service delivery are effective and cost-effective for older
Recommendation ID CG151/1 Question Service provision for neutropenic sepsis in patients with cancer:- A prospective national cohort study
Recommendation ID CG136/3 Question Shared decision-making:- For people using adult mental health services, what are the key aspects of
Recommendation ID CG162/4 Question Shoulder pain:- Which people with a weak arm after stroke are at risk of developing shoulder pain? What
Recommendation ID NG143/8 Question Which signs and symptoms (or combinations of signs and symptoms) predict a diagnosis of Kawasaki disease
Recommendation ID CG151/3 Question Signs and symptoms that predict neutropenic sepsis in the community:- A prospective study should be
Recommendation ID NG44/4 Question Social media:- How effective are online social media and networks at improving health and wellbeing and
Recommendation ID TA599/1 Question The committee noted that there was no clinical evidence showing that having sodium zirconium cyclosilicate
Recommendation ID NG144/5 Question What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD